We have attached herewith outcome of Board Meeting held on Friday, May 29, 2026. Kindly take the same on your record. Thank you.
AHCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anlon Healthcare Limited, a pharmaceutical API manufacturer listed on NSE (AHCL) and BSE (544497), held its Board Meeting on May 29, 2026 and approved audited financial results for FY 2025-26. Consolidated revenue grew 43% to Rs. 17,197 Lakhs from Rs. 12,046 Lakhs. Profit after tax on consolidated basis increased 42% to Rs. 2,909 Lakhs from Rs. 2,052 Lakhs. Standalone revenue rose 47% to Rs. 17,650 Lakhs with PAT at Rs. 2,776 Lakhs. The company operates two subsidiaries - Bizotic Lifescience Private Limited and Apiqo Organics Private Limited. Auditors RVD & Co gave an unmodified opinion. The company also submitted statement of deviation for IPO proceeds utilization.
Strong financial performance with ~42-47% revenue and profit growth indicates robust operational performance. The company appears to have successfully deployed IPO funds. Clean audit opinion is positive for investor confidence.